List of Tables
Table 1. Global Monoclonal Antibodies for Plaque Psoriasis Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Monoclonal Antibodies for Plaque Psoriasis Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Monoclonal Antibodies for Plaque Psoriasis Market Competitive Situation by Manufacturers in 2025
Table 4. Global Monoclonal Antibodies for Plaque Psoriasis Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Monoclonal Antibodies for Plaque Psoriasis Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Monoclonal Antibodies for Plaque Psoriasis Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Monoclonal Antibodies for Plaque Psoriasis Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Monoclonal Antibodies for Plaque Psoriasis Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Monoclonal Antibodies for Plaque Psoriasis, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Monoclonal Antibodies for Plaque Psoriasis, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Monoclonal Antibodies for Plaque Psoriasis, Product Types and Applications
Table 12. Global Key Manufacturers of Monoclonal Antibodies for Plaque Psoriasis, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Monoclonal Antibodies for Plaque Psoriasis Companies by Tier (Tier 1, Tier 2, Tier 3), based on Monoclonal Antibodies for Plaque Psoriasis Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Monoclonal Antibodies for Plaque Psoriasis Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Monoclonal Antibodies for Plaque Psoriasis Sales by Region (K Units), 2021–2026
Table 18. Global Monoclonal Antibodies for Plaque Psoriasis Sales Market Share by Region (2021–2026)
Table 19. Global Monoclonal Antibodies for Plaque Psoriasis Sales by Region (K Units), 2027–2032
Table 20. Global Monoclonal Antibodies for Plaque Psoriasis Sales Market Share by Region (2027–2032)
Table 21. Global Monoclonal Antibodies for Plaque Psoriasis Revenue by Region (US$ Million), 2021–2026
Table 22. Global Monoclonal Antibodies for Plaque Psoriasis Revenue Market Share by Region (2021–2026)
Table 23. Global Monoclonal Antibodies for Plaque Psoriasis Revenue by Region (US$ Million), 2027–2032
Table 24. Global Monoclonal Antibodies for Plaque Psoriasis Revenue Market Share by Region (2027–2032)
Table 25. North America Monoclonal Antibodies for Plaque Psoriasis Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Monoclonal Antibodies for Plaque Psoriasis Sales by Country (K Units), 2021–2026
Table 27. North America Monoclonal Antibodies for Plaque Psoriasis Sales by Country (K Units), 2027–2032
Table 28. North America Monoclonal Antibodies for Plaque Psoriasis Revenue by Country (US$ Million), 2021–2026
Table 29. North America Monoclonal Antibodies for Plaque Psoriasis Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Monoclonal Antibodies for Plaque Psoriasis Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Monoclonal Antibodies for Plaque Psoriasis Sales by Country (K Units), 2021–2026
Table 32. Europe Monoclonal Antibodies for Plaque Psoriasis Sales by Country (K Units), 2027–2032
Table 33. Europe Monoclonal Antibodies for Plaque Psoriasis Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Monoclonal Antibodies for Plaque Psoriasis Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Monoclonal Antibodies for Plaque Psoriasis Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Monoclonal Antibodies for Plaque Psoriasis Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Monoclonal Antibodies for Plaque Psoriasis Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Monoclonal Antibodies for Plaque Psoriasis Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Monoclonal Antibodies for Plaque Psoriasis Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Monoclonal Antibodies for Plaque Psoriasis Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Monoclonal Antibodies for Plaque Psoriasis Sales by Country (K Units), 2021–2026
Table 42. Latin America Monoclonal Antibodies for Plaque Psoriasis Sales by Country (K Units), 2027–2032
Table 43. Latin America Monoclonal Antibodies for Plaque Psoriasis Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Monoclonal Antibodies for Plaque Psoriasis Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Monoclonal Antibodies for Plaque Psoriasis Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Monoclonal Antibodies for Plaque Psoriasis Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Monoclonal Antibodies for Plaque Psoriasis Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Monoclonal Antibodies for Plaque Psoriasis Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Monoclonal Antibodies for Plaque Psoriasis Revenue by Country (US$ Million), 2027–2032
Table 50. Global Monoclonal Antibodies for Plaque Psoriasis Sales (K Units) by Type (2021–2026)
Table 51. Global Monoclonal Antibodies for Plaque Psoriasis Sales (K Units) by Type (2027–2032)
Table 52. Global Monoclonal Antibodies for Plaque Psoriasis Sales Market Share by Type (2021–2026)
Table 53. Global Monoclonal Antibodies for Plaque Psoriasis Sales Market Share by Type (2027–2032)
Table 54. Global Monoclonal Antibodies for Plaque Psoriasis Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Monoclonal Antibodies for Plaque Psoriasis Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Monoclonal Antibodies for Plaque Psoriasis Revenue Market Share by Type (2021–2026)
Table 57. Global Monoclonal Antibodies for Plaque Psoriasis Revenue Market Share by Type (2027–2032)
Table 58. Global Monoclonal Antibodies for Plaque Psoriasis Price (US$/Unit) by Type (2021–2026)
Table 59. Global Monoclonal Antibodies for Plaque Psoriasis Price (US$/Unit) by Type (2027–2032)
Table 60. Global Monoclonal Antibodies for Plaque Psoriasis Sales (K Units) by Application (2021–2026)
Table 61. Global Monoclonal Antibodies for Plaque Psoriasis Sales (K Units) by Application (2027–2032)
Table 62. Global Monoclonal Antibodies for Plaque Psoriasis Sales Market Share by Application (2021–2026)
Table 63. Global Monoclonal Antibodies for Plaque Psoriasis Sales Market Share by Application (2027–2032)
Table 64. Global Monoclonal Antibodies for Plaque Psoriasis Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Monoclonal Antibodies for Plaque Psoriasis Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Monoclonal Antibodies for Plaque Psoriasis Revenue Market Share by Application (2021–2026)
Table 67. Global Monoclonal Antibodies for Plaque Psoriasis Revenue Market Share by Application (2027–2032)
Table 68. Global Monoclonal Antibodies for Plaque Psoriasis Price (US$/Unit) by Application (2021–2026)
Table 69. Global Monoclonal Antibodies for Plaque Psoriasis Price (US$/Unit) by Application (2027–2032)
Table 70. Janssen Biotech, Inc. Company Information
Table 71. Janssen Biotech, Inc. Description and Business Overview
Table 72. Janssen Biotech, Inc. Monoclonal Antibodies for Plaque Psoriasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Janssen Biotech, Inc. Monoclonal Antibodies for Plaque Psoriasis Product
Table 74. Janssen Biotech, Inc. Recent Developments/Updates
Table 75. Biocon Ltd. Company Information
Table 76. Biocon Ltd. Description and Business Overview
Table 77. Biocon Ltd. Monoclonal Antibodies for Plaque Psoriasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Biocon Ltd. Monoclonal Antibodies for Plaque Psoriasis Product
Table 79. Biocon Ltd. Recent Developments/Updates
Table 80. Novartis AG Company Information
Table 81. Novartis AG Description and Business Overview
Table 82. Novartis AG Monoclonal Antibodies for Plaque Psoriasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Novartis AG Monoclonal Antibodies for Plaque Psoriasis Product
Table 84. Novartis AG Recent Developments/Updates
Table 85. Eli Lilly & Co. Company Information
Table 86. Eli Lilly & Co. Description and Business Overview
Table 87. Eli Lilly & Co. Monoclonal Antibodies for Plaque Psoriasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Eli Lilly & Co. Monoclonal Antibodies for Plaque Psoriasis Product
Table 89. Eli Lilly & Co. Recent Developments/Updates
Table 90. Bausch Health Cos., Inc Company Information
Table 91. Bausch Health Cos., Inc Description and Business Overview
Table 92. Bausch Health Cos., Inc Monoclonal Antibodies for Plaque Psoriasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Bausch Health Cos., Inc Monoclonal Antibodies for Plaque Psoriasis Product
Table 94. Bausch Health Cos., Inc Recent Developments/Updates
Table 95. Sun Pharmaceutical Industries Ltd. Company Information
Table 96. Sun Pharmaceutical Industries Ltd. Description and Business Overview
Table 97. Sun Pharmaceutical Industries Ltd. Monoclonal Antibodies for Plaque Psoriasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Sun Pharmaceutical Industries Ltd. Monoclonal Antibodies for Plaque Psoriasis Product
Table 99. Sun Pharmaceutical Industries Ltd. Recent Developments/Updates
Table 100. Almirall SA Company Information
Table 101. Almirall SA Description and Business Overview
Table 102. Almirall SA Monoclonal Antibodies for Plaque Psoriasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Almirall SA Monoclonal Antibodies for Plaque Psoriasis Product
Table 104. Almirall SA Recent Developments/Updates
Table 105. AbbVie, Inc. Company Information
Table 106. AbbVie, Inc. Description and Business Overview
Table 107. AbbVie, Inc. Monoclonal Antibodies for Plaque Psoriasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. AbbVie, Inc. Monoclonal Antibodies for Plaque Psoriasis Product
Table 109. AbbVie, Inc. Recent Developments/Updates
Table 110. UCB, Inc. Company Information
Table 111. UCB, Inc. Description and Business Overview
Table 112. UCB, Inc. Monoclonal Antibodies for Plaque Psoriasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. UCB, Inc. Monoclonal Antibodies for Plaque Psoriasis Product
Table 114. UCB, Inc. Recent Developments/Updates
Table 115. Chongqing Genrix Biopharmaceutical Co., Ltd Company Information
Table 116. Chongqing Genrix Biopharmaceutical Co., Ltd Description and Business Overview
Table 117. Chongqing Genrix Biopharmaceutical Co., Ltd Monoclonal Antibodies for Plaque Psoriasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Chongqing Genrix Biopharmaceutical Co., Ltd Monoclonal Antibodies for Plaque Psoriasis Product
Table 119. Chongqing Genrix Biopharmaceutical Co., Ltd Recent Developments/Updates
Table 120. Jiangsu Hengrui Pharmaceuticals Co., Ltd Company Information
Table 121. Jiangsu Hengrui Pharmaceuticals Co., Ltd Description and Business Overview
Table 122. Jiangsu Hengrui Pharmaceuticals Co., Ltd Monoclonal Antibodies for Plaque Psoriasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Jiangsu Hengrui Pharmaceuticals Co., Ltd Monoclonal Antibodies for Plaque Psoriasis Product
Table 124. Jiangsu Hengrui Pharmaceuticals Co., Ltd Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Monoclonal Antibodies for Plaque Psoriasis Distributors List
Table 128. Monoclonal Antibodies for Plaque Psoriasis Customers List
Table 129. Monoclonal Antibodies for Plaque Psoriasis Market Trends
Table 130. Monoclonal Antibodies for Plaque Psoriasis Market Drivers
Table 131. Monoclonal Antibodies for Plaque Psoriasis Market Challenges
Table 132. Monoclonal Antibodies for Plaque Psoriasis Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
Table 136. Authors List of This Report
List of Figures
Figure 1. Product Picture of Monoclonal Antibodies for Plaque Psoriasis
Figure 2. Global Monoclonal Antibodies for Plaque Psoriasis Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Monoclonal Antibodies for Plaque Psoriasis Market Share by Type: 2025 & 2032
Figure 4. 5-100 mg/mL Product Picture
Figure 5. 100-200 mg/mL Product Picture
Figure 6. Global Monoclonal Antibodies for Plaque Psoriasis Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Monoclonal Antibodies for Plaque Psoriasis Market Share by Application: 2025 & 2032
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Others
Figure 11. Global Monoclonal Antibodies for Plaque Psoriasis Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global Monoclonal Antibodies for Plaque Psoriasis Market Size (US$ Million), 2021–2032
Figure 13. Global Monoclonal Antibodies for Plaque Psoriasis Sales (K Units), 2021–2032
Figure 14. Global Monoclonal Antibodies for Plaque Psoriasis Average Price (US$/Unit), 2021–2032
Figure 15. Monoclonal Antibodies for Plaque Psoriasis Report Years Considered
Figure 16. Monoclonal Antibodies for Plaque Psoriasis Sales Share by Manufacturers in 2025
Figure 17. Global Monoclonal Antibodies for Plaque Psoriasis Revenue Share by Manufacturers in 2025
Figure 18. Top 5 and Top 10 Global Monoclonal Antibodies for Plaque Psoriasis Players: Market Share by Revenue in Monoclonal Antibodies for Plaque Psoriasis in 2025
Figure 19. Monoclonal Antibodies for Plaque Psoriasis Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 20. Global Monoclonal Antibodies for Plaque Psoriasis Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 21. North America Monoclonal Antibodies for Plaque Psoriasis Sales Market Share by Country (2021–2032)
Figure 22. North America Monoclonal Antibodies for Plaque Psoriasis Revenue Market Share by Country (2021–2032)
Figure 23. United States Monoclonal Antibodies for Plaque Psoriasis Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Canada Monoclonal Antibodies for Plaque Psoriasis Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Europe Monoclonal Antibodies for Plaque Psoriasis Sales Market Share by Country (2021–2032)
Figure 26. Europe Monoclonal Antibodies for Plaque Psoriasis Revenue Market Share by Country (2021–2032)
Figure 27. Germany Monoclonal Antibodies for Plaque Psoriasis Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. France Monoclonal Antibodies for Plaque Psoriasis Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. U.K. Monoclonal Antibodies for Plaque Psoriasis Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Italy Monoclonal Antibodies for Plaque Psoriasis Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Russia Monoclonal Antibodies for Plaque Psoriasis Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Asia Pacific Monoclonal Antibodies for Plaque Psoriasis Sales Market Share by Region (2021–2032)
Figure 33. Asia Pacific Monoclonal Antibodies for Plaque Psoriasis Revenue Market Share by Region (2021–2032)
Figure 34. China Monoclonal Antibodies for Plaque Psoriasis Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Japan Monoclonal Antibodies for Plaque Psoriasis Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. South Korea Monoclonal Antibodies for Plaque Psoriasis Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. India Monoclonal Antibodies for Plaque Psoriasis Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Australia Monoclonal Antibodies for Plaque Psoriasis Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. China Taiwan Monoclonal Antibodies for Plaque Psoriasis Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Southeast Asia Monoclonal Antibodies for Plaque Psoriasis Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Latin America Monoclonal Antibodies for Plaque Psoriasis Sales Market Share by Country (2021–2032)
Figure 42. Latin America Monoclonal Antibodies for Plaque Psoriasis Revenue Market Share by Country (2021–2032)
Figure 43. Mexico Monoclonal Antibodies for Plaque Psoriasis Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Brazil Monoclonal Antibodies for Plaque Psoriasis Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Argentina Monoclonal Antibodies for Plaque Psoriasis Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Colombia Monoclonal Antibodies for Plaque Psoriasis Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Middle East and Africa Monoclonal Antibodies for Plaque Psoriasis Sales Market Share by Country (2021–2032)
Figure 48. Middle East and Africa Monoclonal Antibodies for Plaque Psoriasis Revenue Market Share by Country (2021–2032)
Figure 49. Turkey Monoclonal Antibodies for Plaque Psoriasis Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Saudi Arabia Monoclonal Antibodies for Plaque Psoriasis Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. UAE Monoclonal Antibodies for Plaque Psoriasis Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Global Sales Market Share of Monoclonal Antibodies for Plaque Psoriasis by Type (2021–2032)
Figure 53. Global Revenue Market Share of Monoclonal Antibodies for Plaque Psoriasis by Type (2021–2032)
Figure 54. Global Monoclonal Antibodies for Plaque Psoriasis Price (US$/Unit) by Type (2021–2032)
Figure 55. Global Sales Market Share of Monoclonal Antibodies for Plaque Psoriasis by Application (2021–2032)
Figure 56. Global Revenue Market Share of Monoclonal Antibodies for Plaque Psoriasis by Application (2021–2032)
Figure 57. Global Monoclonal Antibodies for Plaque Psoriasis Price (US$/Unit) by Application (2021–2032)
Figure 58. Monoclonal Antibodies for Plaque Psoriasis Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
